Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  epirubicin hydrochloride
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients with High-Risk Stage IIB-IV Soft Tissue Sarcoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: IRB00009464, NCI-2013-02414, NCT02050919
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients with Triple Negative Stage II-III Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 041401, NCI-2014-02029, NCT02315196
Combination Chemotherapy and Pembrolizumab in Treating Patients with Previously Untreated Localized Gastric or Gastroesophageal Junction
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AAAQ9871, NCI-2017-00556, NCT02918162
Paclitaxel and Carboplatin before Surgery in Treating Nigerian Women with Stage IIA-IIIC Breast Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 70
Trial IDs: IRB15-1005, NCI-2017-00754, NCT03058939
Molecular Profile-Directed Chemotherapy in Treating Patients with Metastatic HER2 Negative Esophagogastric Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2013-0973, NCI-2014-02639, NCT02358863
Start Over